{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T06:08:00Z","timestamp":1772950080261,"version":"3.50.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011318","name":"Fondation Botnar","doi-asserted-by":"publisher","award":["REG-19-008"],"award-info":[{"award-number":["REG-19-008"]}],"id":[{"id":"10.13039\/501100011318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["PCEFP3_181355"],"award-info":[{"award-number":["PCEFP3_181355"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["P500PM_221966"],"award-info":[{"award-number":["P500PM_221966"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["323530_221860"],"award-info":[{"award-number":["323530_221860"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005688","name":"Gottfried and Julia Bangerter-Rhyner Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"publisher","award":["3ZX1422"],"award-info":[{"award-number":["3ZX1422"]}],"id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015075","name":"Janggen P\u00f6hn Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Children and adolescents with HIV have lower treatment success than adults. Suboptimal adherence and resistance to antiretroviral therapy (ART) are known aetiological factors. This preplanned analysis in the GIVE MOVE trial (NCT04233242) describes drug resistance patterns in children and adolescents in Lesotho and Tanzania.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>GIVE MOVE randomized children and adolescents (6\u2005months to below 19\u2005years) with recent viraemia whilst taking ART to genotypic resistance testing (GRT)-informed care or usual care. Here, we conducted additional post-hoc GRT on stored samples from both groups and included participants with at least one successful resistance test. We assessed the number of drugs predicted to be active in participants\u2019 three-drug ART regimens and resistance-associated mutations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Amongst 137 participants, the majority were female (58%) and lived in Lesotho (77%). At their initial GRT, 69\/137 (50%) were receiving protease inhibitor-based, 59\/137 (43%) dolutegravir-based and 9\/137 (7%) efavirenz-based ART. At that time, 80\/137 (58%) participants had three, whilst 8\/137 (6%) had two, 36\/137 (26%) had one and 13\/137 (9%) had no drugs predicted to be active in their regimens. Seventeen (12%) participants had resistance against their ART core agent, including one with high-level dolutegravir resistance.<\/jats:p>\n                    <jats:p>Across 312 detected resistance-associated mutations (222 major, 90 accessory), 146 conferred resistance to non-nucleoside reverse transcriptase inhibitors, 127 to nucleoside reverse transcriptase inhibitors, 28 to protease inhibitors and 11 to integrase strand transfer inhibitors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Given that more than half had an ART regimen predicted to be fully active, most viraemia in children and adolescents could not be explained by resistance.<\/jats:p>\n                    <jats:p>Registration: The GIVE MOVE trial was registered on Clinicaltrials.gov NCT04233242<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkag070","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T12:42:25Z","timestamp":1771072945000},"source":"Crossref","is-referenced-by-count":0,"title":["HIV drug resistance amongst children and adolescents with viraemia in Lesotho and Tanzania: a nested analysis in the GIVE MOVE trial"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9856-3500","authenticated-orcid":false,"given":"Christof Manuel","family":"Sch\u00f6nenberger","sequence":"first","affiliation":[{"name":"Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel , Basel ,","place":["Switzerland"]},{"name":"University of Basel , Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7771-8608","authenticated-orcid":false,"given":"Kathrin","family":"Haenggi","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel , Basel ,","place":["Switzerland"]},{"name":"University of Basel , Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac Kaumbuthu","family":"Ringera","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel , Basel ,","place":["Switzerland"]},{"name":"University of Basel , Basel ,","place":["Switzerland"]},{"name":"SolidarMed, Partnerships for Health , Maseru ,","place":["Lesotho"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7979-3132","authenticated-orcid":false,"given":"Ezekiel","family":"Luoga","sequence":"additional","affiliation":[{"name":"Department of Biomedical Research and Clinical Trials, Ifakara Health Institute , Ifakara ,","place":["Tanzania"]},{"name":"St.Francis Referral Hospital , Ifakara ,","place":["Tanzania"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8410-7910","authenticated-orcid":false,"given":"Moniek","family":"Bresser","sequence":"additional","affiliation":[{"name":"University of Basel , Basel ,","place":["Switzerland"]},{"name":"Department of Medicine, Swiss Tropical and Public Health Institute , Allschwil ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buoang","family":"Mothobi","sequence":"additional","affiliation":[{"name":"SolidarMed, Partnerships for Health , Maseru ,","place":["Lesotho"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuena","family":"Mokhele","sequence":"additional","affiliation":[{"name":"SolidarMed, Partnerships for Health , Maseru ,","place":["Lesotho"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0246-8195","authenticated-orcid":false,"given":"David","family":"Sando","sequence":"additional","affiliation":[{"name":"Department of Development Studies, Muhimbili University of Health and Allied Sciences , Dar es Salaam ,","place":["Tanzania"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamello","family":"Molatelle","sequence":"additional","affiliation":[{"name":"Seboche Mission Hospital , Seboche ,","place":["Lesotho"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4467-4029","authenticated-orcid":false,"given":"Lineo","family":"Thahane","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine Children's Foundation Lesotho , Maseru ,","place":["Lesotho"]},{"name":"Baylor College of Medicine , Houston, TX ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0888-7166","authenticated-orcid":false,"given":"Dorcas","family":"Mnzava","sequence":"additional","affiliation":[{"name":"Department of Biomedical Research and Clinical Trials, Ifakara Health Institute , Ifakara ,","place":["Tanzania"]},{"name":"HPV Laboratory, Department of Gynaecology, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin , Berlin ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1253-8970","authenticated-orcid":false,"given":"Robert","family":"Ndege","sequence":"additional","affiliation":[{"name":"University of Basel , Basel ,","place":["Switzerland"]},{"name":"Department of Biomedical Research and Clinical Trials, Ifakara Health Institute , Ifakara ,","place":["Tanzania"]},{"name":"St.Francis Referral Hospital , Ifakara ,","place":["Tanzania"]},{"name":"Department of Medicine, Swiss Tropical and Public Health Institute , Allschwil ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mosa Molapo","family":"Hlasoa","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine Children's Foundation Lesotho , Maseru ,","place":["Lesotho"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buntshi Paulin","family":"Kayembe","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine Children's Foundation Lesotho , Maseru ,","place":["Lesotho"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1314-4543","authenticated-orcid":false,"given":"Josephine","family":"Muhairwe","sequence":"additional","affiliation":[{"name":"SolidarMed, Partnerships for Health , Maseru ,","place":["Lesotho"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7075-9803","authenticated-orcid":false,"given":"Tracy Ren\u00e9e","family":"Glass","sequence":"additional","affiliation":[{"name":"University of Basel , Basel ,","place":["Switzerland"]},{"name":"Department of Medicine, Swiss Tropical and Public Health Institute , Allschwil ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4945-6511","authenticated-orcid":false,"given":"Thomas","family":"Klimkait","sequence":"additional","affiliation":[{"name":"University of Basel , Basel ,","place":["Switzerland"]},{"name":"Molecular Virology, Department of Biomedicine, University of Basel , Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0134-1929","authenticated-orcid":false,"given":"Maja","family":"Weisser","sequence":"additional","affiliation":[{"name":"University of Basel , Basel ,","place":["Switzerland"]},{"name":"Department of Biomedical Research and Clinical Trials, Ifakara Health Institute , Ifakara ,","place":["Tanzania"]},{"name":"Department of Medicine, Swiss Tropical and Public Health Institute , Allschwil ,","place":["Switzerland"]},{"name":"Division of Infectious Diseases, University Hospital Basel , Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3599-1791","authenticated-orcid":false,"given":"Niklaus Daniel","family":"Labhardt","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel , Basel ,","place":["Switzerland"]},{"name":"University of Basel , Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7303-9542","authenticated-orcid":false,"given":"Nadine","family":"Tschumi","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel , Basel ,","place":["Switzerland"]},{"name":"University of Basel , Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1874-6153","authenticated-orcid":false,"given":"Jennifer Anne","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel , Basel ,","place":["Switzerland"]},{"name":"University of Basel , Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"2026030712201035100_dkag070-B1","unstructured":"HIV\/AIDS data . UNICEF DATA (In en-US). https:\/\/data.unicef.org\/resources\/dataset\/hiv-aids-statistical-tables\/files\/1011\/hiv-aids-statistical-tables.html."},{"key":"2026030712201035100_dkag070-B2","author":"Unaids"},{"key":"2026030712201035100_dkag070-B3"},{"key":"2026030712201035100_dkag070-B4","doi-asserted-by":"publisher","first-page":"e766","DOI":"10.1016\/S2352-3018(21)00265-4","article-title":"Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries","volume":"8","author":"Han","year":"2021","journal-title":"Lancet HIV"},{"key":"2026030712201035100_dkag070-B5","doi-asserted-by":"publisher","first-page":"e1002183","DOI":"10.1371\/journal.pmed.1002183","article-title":"Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis","volume":"13","author":"Shubber","year":"2016","journal-title":"PLoS Med"},{"key":"2026030712201035100_dkag070-B6","doi-asserted-by":"publisher","first-page":"e658","DOI":"10.1016\/S2352-3018(22)00101-1","article-title":"Advancing the prevention and treatment of HIV in children: priorities for research and development","volume":"9","author":"Penazzato","year":"2022","journal-title":"Lancet HIV"},{"key":"2026030712201035100_dkag070-B7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40471-021-00268-3","article-title":"HIV drug resistance in children and adolescents: always a challenge?","volume":"8","author":"Koay","year":"2021","journal-title":"Curr Epidemiol Rep"},{"key":"2026030712201035100_dkag070-B8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1186\/s12879-020-05491-9","article-title":"Genotype-Informed Versus Empiric Management of VirEmia (GIVE MOVE): study protocol of an open-label randomised clinical trial in children and adolescents living with HIV in Lesotho and Tanzania","volume":"20","author":"Brown","year":"2020","journal-title":"BMC Infect Dis"},{"key":"2026030712201035100_dkag070-B9","doi-asserted-by":"publisher","first-page":"e1312","DOI":"10.1016\/S2214-109X(24)00183-9","article-title":"Resistance-informed versus empirical management of viraemia in children and adolescents with HIV in Lesotho and Tanzania (GIVE MOVE trial): a multisite, open-label randomised controlled trial","volume":"12","author":"Brown","year":"2024","journal-title":"Lancet Glob Health"},{"key":"2026030712201035100_dkag070-B10","author":"World Health Organization"},{"key":"2026030712201035100_dkag070-B11","author":"WHO"},{"key":"2026030712201035100_dkag070-B12","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/qad.0000000000003835","article-title":"HIV viral suppression in children and adolescents 2years after transition to dolutegravir: a multicentre cohort study","volume":"38","author":"Devendra","year":"2024","journal-title":"AIDS"},{"key":"2026030712201035100_dkag070-B13","doi-asserted-by":"publisher","first-page":"e26474","DOI":"10.1002\/jia2.26474","article-title":"Low-level viraemia as a risk factor for virologic failure in children and adolescents living with HIV on antiretroviral therapy in Tanzania: a multicentre, retrospective cohort study","volume":"28","author":"McKenzie","year":"2025","journal-title":"J Int AIDS Soc"},{"key":"2026030712201035100_dkag070-B14","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000004432","article-title":"Tolerability of lopinavir versus dolutegravir in children and adolescents with HIV (LoDoCA): a prospective cohort study in Lesotho, Southern Africa","author":"Blankenberger","year":"2026","journal-title":"Aids"},{"key":"2026030712201035100_dkag070-B15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"2026030712201035100_dkag070-B16","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1086\/503914","article-title":"Web resources for HIV type 1 genotypic-resistance test interpretation","volume":"42","author":"Liu","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2026030712201035100_dkag070-B17","doi-asserted-by":"publisher","first-page":"102859","DOI":"10.1016\/j.eclinm.2024.102859","article-title":"Global, regional, and national prevalence of HIV-1 drug resistance in treatment-naive and treatment-experienced children and adolescents: a systematic review and meta-analysis","volume":"77","author":"Ge","year":"2024","journal-title":"EClinicalMedicine"},{"key":"2026030712201035100_dkag070-B18","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.3390\/v15102083","article-title":"HIV drug resistance patterns and characteristics associated with clinically significant drug resistance among children with virologic failure on antiretroviral treatment in Kenya: findings from the Opt4Kids randomized controlled trial","volume":"15","author":"Abuogi","year":"2023","journal-title":"Viruses"},{"key":"2026030712201035100_dkag070-B19","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1056\/NEJMoa2108793","article-title":"Dolutegravir as first- or second-line treatment for HIV-1 infection in children","volume":"385","author":"Turkova","year":"2021","journal-title":"N Engl J Med"},{"key":"2026030712201035100_dkag070-B20","doi-asserted-by":"publisher","first-page":"ciaf444","DOI":"10.1093\/cid\/ciaf444","article-title":"Approaches to the management of virologic failure on dolutegravir-based antiretroviral therapy in the 50 countries with the highest adult HIV prevalence","author":"Nutt","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026030712201035100_dkag070-B21","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/cid\/ciae185","article-title":"Emergence of acquired Dolutegravir resistance in treatment-experienced people with HIV in Lesotho","volume":"79","author":"Tschumi","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026030712201035100_dkag070-B22","doi-asserted-by":"publisher","first-page":"e733","DOI":"10.1016\/S2352-3018(23)00228-X","article-title":"HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis","volume":"10","author":"Loosli","year":"2023","journal-title":"Lancet HIV"},{"key":"2026030712201035100_dkag070-B23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/cid\/ciae261","article-title":"Virologic failure and drug resistance after programmatic switching to dolutegravir-based first-line antiretroviral therapy in Malawi and Zambia","volume":"80","author":"Skrivankova","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026030712201035100_dkag070-B24","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1093\/cid\/ciaf204","article-title":"Drug resistance in people with viremia on dolutegravir-based antiretroviral therapy in sub-saharan Africa: the DTG RESIST study","volume":"81","author":"Loosli","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026030712201035100_dkag070-B25","author":"Ministry of Health GoL, Locations"},{"key":"2026030712201035100_dkag070-B26","doi-asserted-by":"publisher","first-page":"e698","DOI":"10.1016\/S2214-109X(24)00553-9","article-title":"Predicted dolutegravir resistance in people living with HIV in South Africa during 2020\u201335: a modelling study","volume":"13","author":"Loosli","year":"2025","journal-title":"Lancet Glob Health"},{"key":"2026030712201035100_dkag070-B27","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1016\/s2352-3018(25)00164-x","article-title":"The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir\u2013lamivudine\u2013dolutegravir in South Africa: a modelling study","volume":"12","author":"Hyle","year":"2025","journal-title":"Lancet HIV"},{"key":"2026030712201035100_dkag070-B28","doi-asserted-by":"publisher","first-page":"e578","DOI":"10.1016\/s2352-3018(25)00068-2","article-title":"Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling study","volume":"12","author":"Phillips","year":"2025","journal-title":"Lancet HIV"},{"key":"2026030712201035100_dkag070-B29","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.7326\/m21-2229","article-title":"Resistance testing for management of HIV virologic failure in sub-Saharan Africa: an unblinded randomized controlled trial","volume":"174","author":"Siedner","year":"2021","journal-title":"Ann Intern Med"},{"key":"2026030712201035100_dkag070-B30","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1093\/cid\/ciaf337","article-title":"A real-time urine Tenofovir assay improves drug adherence among people with HIV with prior virologic failure in a randomized controlled trial","volume":"81","author":"van Zyl","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026030712201035100_dkag070-B31","doi-asserted-by":"publisher","first-page":"e050116","DOI":"10.1136\/bmjopen-2021-050116","article-title":"Simplifying TREAtment and monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes","volume":"11","author":"Bardon","year":"2021","journal-title":"BMJ Open"},{"key":"2026030712201035100_dkag070-B32","author":"Gandhi"},{"key":"2026030712201035100_dkag070-B33","author":"McCluskey"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/4\/dkag070\/67272305\/dkag070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/4\/dkag070\/67272305\/dkag070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:20:22Z","timestamp":1772904022000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag070\/8510605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag070","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,4]]},"article-number":"dkag070"}}